Lichen sclerosus in women

Clinics in Dermatology

Volumn 15, Issue 1, 1997, Pages 155-169

  Wakelin, Sarah H ^a   Marren, Pauline ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INJURY; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VULVA DISEASE;

EID: 0031081196     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00118-6     Document Type: Article

References (131)

1. 1. Wallace HJ. Lichen sclerosus et atrophicus. Trans Rep St John's Hospital Dermatol Soc 1971;57:9-30.
2. 2. Ridley CM. Dermatological conditions. In: The vulva. London, Churchill Livingstone, Longman UK Ltd, 1988: 172-88.
3. 3. International Society for the Study of Vulvar Disease. New nomenclature for vulvar disease. Obstet Gynecol 1976;47:122-4.
4. 4. Ridley CM, Frankman O, Jones ISC, et al. New nomenclature for vulvar diseases. International Society for the Study of Vulvar Diseases (letter). Hum Pathol 1989; 20:495-6.
5. 5. Hallopeau H. Leçons clinique sur les maladées cutanées et syphiliques. Union Med Can 1887;43:472.
6. 6. Darier J. Lichen plan scléreux. Ann Dermatol Syphilol 1892;23:833-7.
7. 7. Brieski A. Über kraurosis vulvae. Z Heilkr 1885;6:69-80.
8. 8. Westberg F. Ein fall von mit weissen flecken Einherhehender, bisher nicht bekannten Dermatose. Monatschr Prakt Dermatol 1901;33:355-61.
9. 9. Montgomery FH, Ormsby OS. White spot disease (morphea guttata) and lichen planus sclerosus et atrophicus. J Cutan Dis 1907;25:1-16.
10. 10. Stühmer A. Balanitis xerotica obliterans (postoperationem) und ihre beziehungen zur Kraurosis blandis et preaeputii penis. Arch Dermatol Syph (Berlin) 1928;156: 613-23.
11. 11. Ridley CM. Lichen sclerosus et atrophicus. Arch Dermatol 1987;123:457-60.
12. 12. Montgomery H, Hill WR. Lichen sclerosus et atrophicus. Arch Dermatol Syphilol 1940;42:755-79.
13. 13. Garcia-Bravo B, Sanchez-Pedreno P, Rodriguez-Pichardo A, et al. Lichen sclerosus et atrophicus: A study of 76 cases and their relation to diabetes. J Am Acad Dermatol 1988;19:482-5.
14. 14. Fischer G, Spurrett B, Fischer A. The chronically symptomatic vulva: aetiology and management. Br J Obstet Gynecol 1995;102:773-9
15. 15. Sideri M, Parazzini F, Rognoni MT, et al. Risk factors for vulval lichen sclerosus et atrophicus. Am J Obst Gynecol 1989;161:38-42.
16. 16. Marren P, Cherry C, Day A, et al. Lichen sclerosus: The patient, the hormonal influences and disease impact. Br J Dermatol 1995;21:133 suppl 45 [Abstr]
17. 17. Preti M, Micheletti L, Barbero M, et al. Psychological distress in women with non-neoplastic epithelial disorders of the vulva. J Reprod Med 1994;39:961-3.
18. 18. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity - a study of 350 women. Br J Dermatol 1988;118:41-6.
19. 19. Kaufman RH, Faro S. Non-neoplastic epithelial disorders of the vulvar skin and mucosa. In: Kaufman RH, Faros, editors. Benign dieseases of the vulva. 4th ed. St. Louis: Mosby-Year Book, 1994:260-82.
20. 20. Chernoski ME, Derbes VJ, Burke JW. Lichen sclerosus et atrophicus in children. Arch Dermatol 1957;75:647-52.
21. 21. Schulten EA, Starink TM, van der Waal I. Lichen sclerosus et atrophicus involving the oral mucosa: report of two cases. J Oral Pathol Med 1993;22:374-7.
22. 22. Ravits HG, Welsh AL. Lichen sclerosus et atrophicus of the mouth. Arch Dermatol 1957;76:56-8.
23. 23. Marren P, De Berker D, Millard P, et al. Bullous and haemorrhagic lichen sclerosus with scalp involvement. Clin Exp Dermatol 1992;17:354-6.
24. 24. Petrozzi JW, Wood MG, Tisa V. Palmar-plantar lichen sclerosus. Arch Dermatol 1979;115:884.
25. 25. Weigand DA. Microscopic features of lichen sclerosus et atrophicus in acrocordons: a clue to the cause of lichen sclerosus et atrophicus? J Am Acad Dermatol 1993;28: 751-4.
26. 26. Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995;40:351-4.
27. 27. Rabinowitz LG. Lichen sclerosus treatment with the 585-nm flashlamp-pumped pulsed dye laser. Arch Dermatol 1993;129:381-2.
28. 28. Loening-Baucke V. Lichen sclerosus et atrophicus in children. Am J Dis Child 1991;145:1058-61.
29. 29. DiSilvero A, Serri F. Generalised bullous and haemorrhagic lichen sclerosus et atrophicus - marked improvement with ACTH. Br J Dermatol 1975;93:215-7.
30. 30. Brodey A. Haemorrhagic and bullous lichen sclerosus et atrophicus. Arch Dermatol 1967;95:328-30.
31. 31. Glickmann FG, Silvers SH. Generalised bullous and haemorrhagic lichen sclerosus et atrophicus. Cutis 1972; 10:501-3.
32. 32. Wakelin SH, James MP. Extensive lichen sclerosus et atrophicus with bullae and ulceration - improvement with hydroxychloroquine. Clin Exp Dermatol 1994;19: 332-4.
33. 33. Hart WR, Norris HJ, Helwig EB. Relation of lichen sclerosus et atrophicus of the vulva to the development of carcinoma. Obstet Gynecol 1975;45:369-77.
34. 34. Ridley CM. Lichen sclerosus. Dermatol Clin 1992;10:309-19.
35. 35. Goolamali SK, Barnes EW, Irvine WJ, et al. Organ specific antibodies in patients with lichen sclerosus. Br Med J 1974;vi:78-9.
36. 36. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune related disease in males. Br J Dermatol 1983;109:661-4.
37. 37. Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995;132:197-203.
38. 38. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus et atrophicus. Br J Dermatol 1981;104: 563-6.
39. 39. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatol 1995;32:393-461.
40. 40. Freidrich EG, MacLaren NK. Genetic aspects of vulvar lichen sclerosus. Am J Obst Gynecol 1984;150:161-5.
41. 41. Sahn EE, Bluestein EL, Oliva S. Familial lichen sclerosus et atrophicus in childhood. Paed Dermatol 1994;11:160-3.
42. 42. Meyrick Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in twin girls. Br J Dermatol 1986;114:337-9.
43. 43. Meyrick Thomas RH, Ridley CM, Sherwood F, et al. The lack of association of lichen sclerosus et atrophicus with HLA-A and B tissue antigens. Clin Exp Dermatol 1984; 9:290-2.
44. 44. Holt PJA, Darke C. HLA antigens and Bf allotypes in lichen sclerosus et atrophicus. Tissue Antigens 1983;22: 89-91.
45. 45. Purcell KG, Spencer LV, Simpson PM, et al. HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol 1990;126:1043-5.
46. 46. Sideri M, Rognoni M, Rizzolo L, et al. Antigens of the HLA system in women with lichen sclerosus et atrophicus. J Reprod Med 1988,33:551-4.
47. 47. Wakelin SH, Mallon E, Wojnarowska F, et al. Increased frequency of HLA DQ7 in female patients with cicatricial pemphigoid. Br J Dermatol 1995;132:651 [Abstr].
48. 48. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994;94:407-10.
49. 49. Dinarello CA, Thompson RC. Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 1991;12:404-10.
50. 50. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103:387-90.
51. 51. Blakemore AI, Tarlow JK, Cork MJ, et al. II-1 receptor antagonist gene polymorphism as a disease severity factor in SLE. Arth Rheum 1994;37:1380-5.
52. 52. Friedrich EG, Kalra PS. Serum levels of sex hormones in vulval lichen sclerosus and the effect of topical testosterone. N Engl J Med 1984;308:488-91.
53. 53. Cantwell AR. Histological observations of variably acid-fast bacteria in scleroderma, morphoea and lichen sclerosus et atrophicus. Int J Dermatol 1984;23:45-52.
54. 54. Asbrink E, Hovmark A. Cutaneous manifestations in Ixodes-borne Borrelia spirochetosis. Int J Dermatol 1987;26: 215-23.
55. 55. Aberer E, Neumann R, Lubec G. Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms. Acta Dermatol Venereol (Stockh) 1987;67:62-5.
56. 56. Aberer E, Neumann R, Stanek G. Is localised scleroderma a Borrelial infection? Lancet 1985;ii:278.
57. 57. Beuchner SA, Rufli T. Atrophoderma of Pasini and Pierini. Clinical and histological findings and antibodies to Borrelia burgdorferi in 34 patients. J Am Acad Dermatol 1994;30:441-6.
58. 58. Ross SA, Sanchez JL, Taboas JO. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus. Am J Dermatopathol 1990;12:357-62.
59. 59. Aberer E, Stanek G. Histological evidence for spirochete forms in the dermal lesions of morphoea and lichen sclerosus et atrophicus. Am J Dermatopathol 1987;9:374-9.
60. 60. Hoesly JM, Mertz LE, Winklemann RK. Localised scleroderma (morphoea) and antibody to Borrelia burgdorferi. J Am Acad Dermatol 1987;17:455-8.
61. 61. Vailant L, Goudeau A. Localised scleroderma is not a Borrelia burgdorferi infection in France (letter). Dermatology 1992;184:286.
62. 62. Schempp C, Bocklage H, Lange R, et al. Further evidence for Borrelia burgdorferi infection in morphoea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993;100:717-20.
63. 63. Dillon WI, Saeed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymearse chain reaction in skin lesions of morphoea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995,33:617-20.
64. 64. Ronnen M, Suster S, Kahana M, et al. Bilateral Kobner phenomenon in lichen sclerosus et atrophicus. Int J Dermatol 1987;26:117-8.
65. 65. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin Exp Dermatol 1988;13:36-7.
66. 66. Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol 1985; 121:1044-7.
67. 67. Barker LP, Gross P. Lichen sclerosus of the female genitalia. Arch Dermatol 1962;85:102-3.
68. 68. Pock L. Kobner phenomenon in lichen sclerosus et atrophicus. Dermatologica 1990;181:76-7.
69. 69. Meffert JJ, Grim wood RE. Lichen sclerosus et atrophicus appearing in an old burn scar. J Am Acad Dermatol 1994; 31:671-3.
70. 70. Whimster IW. The natural history of skin malignancy. Br J Dermatol 1965;77:534-5.
71. 71. Douglas CP, Barnes FJ. Proteolytic enzyme activity measured on extracellular matrix in vulvar dystrophies. Am J Obstet Gynecol 1986;6:193-5.
72. 72. Romppanen U, Rantala I, Lauslahti K, et al. Light and electron microscopic findings in lichen sclerosus of the vulva during etretinate treatment. Dermatologica 1987; 175:33-10.
73. 73. Godeau G, Frances C, Hornebeck W, et al. Isolation and partial characterisation of an elastase-type protease in human vulval fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus. J Invest Dermatol 1982;78:270-9.
74. 74. Oikarinen A, Sandberg M, Hurskainen T. Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridisation techniques. Acta Derm Venereol (Stockh) Suppl 1991;162:3-12.
75. 75. Griffiths MR, Priestly GC. A comparison of morphoea and lichen sclerosus atrophicus in vitro: the effects of para-aminobenzoate on skin fibroblasts. Acta Derm Venereol (Stockh) 1992;72:15-8.
76. 76. Panizzon R, Vuorio T, Bruckner-Tuderman L. Collagen biosynthesis and type I and type III procollagen mRNA in lichen sclerosus et atrophicus. Arch Dermatol Res 1990;282:480-3.
77. 77. Barnes CJ, Douglas CP. Preliminary findings on levels of collagenase and its tissue inhibitor in some vulval dystrophies. J Obstet Gynecol 1985;6:55.
78. 78. Betti R, Lodi A, Marmini A, et al. T cell peripheral subsets in lichen sclerosus et atrophicus. Br J Dermatol 1986; 11:569-73.
79. 79. Carli P, Cattaneo A, Pimpinelli N, et al. Immunohistological evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991;182:18-22.
80. 80. Auboch J, Romani N, Grubauer G, et al. HLA-DR expression on keratinocytes is a common feature of diseased skin. Br J Dermatol 1986;114:465-72.
81. 81. DeOliveira JM, Saliero V. Involucrin expression in vulva lesions. J Reprod Med 1986;31:828-30.
82. 82. Romero LI, Pincus SH. In situ localisation of interleukin-6 in normal skin and atrophic cutaneous disease. Int Arch Allerg Immunol 1992;99:44-9.
83. 83. Tan S-H, Derrick E, McKee P, et al. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994;21:316-23.
84. 84. Soini Y, Paakko P, Vahakangas K, et al. Expression of P53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features. Int J Gynae Pathol 1994;13:199-204.
85. 85. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations of the p53 gene occur in a diverse range of human tumour types. Nature 1989;342:705-8.
86. 86. Campbell C, Quinn AG, Ro Y-S, et al. P53 mutations are common and early events that precede tumour invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993;100:746-8.
87. 87. Lever WF, Schaumberg-Lever G. Histopathology of the skin. 7th ed. Philadelphia: JB Lippincott, 1990:308-9.
88. 88. Rahbari H. Histochemical differentiation of localised morphea-scleroderma and lichen sclerosus et atrophicus. J Cutan Pathol 1989;16:342-7.
89. 89. Mihara Y, Mihara M, Hagari Y, et al. Lichen sclerosus et atrophicus. A histological, immunohistological and electron microscopic study. Arch Derm Res 1994;286:434-42.
90. 90. Miller NF, Parrott MH, Stryker J, et al. Leukoplakia of the vulva: preliminary report. Am J Obst Gynecol 1947; 54:543-60.
91. 91. Leibowitch M, Neil S, Pelisse M, et al. The epithelial changes associated with squamous cell carcinoma of the vulva; a review of the clinical, histological and virological findings in 78 women. Br J Obstet Gynecol 1990;97: 1135-9.
92. 92. Mann PR, Cowan MA. Ultrastructural changes in four cases of lichen sclerosus et atrophicus. Br J Dermatol 1973;89:223-31.
93. 93. Jai-bi W, Hong Y, Han-ying Y. Histopathological and ultrastructural changes of lichen sclerosus et atrophicus on the vulva. Chinese Med J 1991;104:868-71.
94. 94. Marren P, Charnock M, Wojnarowska F. Basement membrane alteration in lichen sclerosus: cause or effect? Br J Dermatol 1994;131(suppl 44):83 [Abstr].
95. 95. Dupré A, Viraben R. Lame basale en guirlande dans un cas de lichen scléroatrophique, étude ultrastructurale. Ann Dermatol Venereol 1988;115:19-26.
96. 96. Kint A, Geerts ML. Lichen sclerosus et atrophicus. An electron microscopic study. J Cutan Pathol 1975;2:30-4.
97. 97. Uitto J, SantaCruz DJ, Bauer EA, et al. Morphoea and lichen sclerosus et atrophicus. J Am Acad Dermatol 1980; 3:271-9.
98. 98. Gordon W, Kahn LB, Dove J. Lichen sclerosus et atrophicus and scleroderma. S Afr Med J 1972;46:160-3.
99. 99. Connelly MG, Winklemann RK. Coexistence of lichen sclerosus, morphoea and lichen planus. Report of four cases and review of the literature. J Am Acad Dermatol 1985;12:844-51.
100. 100. Marren P, Millard P, Chia Y, et al. Mucosal lichen sclerosus/lichen planus overlap syndromes. Br J Dermatol 1994;131:118-23.
101. 101. Patterson KA, Ackerman AB. Lichen sclerosus et atrophicus is not related to morphea. Am J Dermatopath 1984;6:323-35.
102. 102. Dalziel KL, Wojnarowska F, Millard P. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%). Br J Dermatol 1991;124: 461-4.
103. 103. Marren P, Woljnarowska F, Powell S. Allergic contact dermatitis and vulvar dermatoses. Br J Dermatol 1992; 126:52-6.
104. 104. Dalziel KI, Woljnarowska F. Long-term control of lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993;38:25-7.
105. 105. Bracco GL, Carli P, Sonni L, et al. Clinical and histological effects of topical treatments of vulval lichen sclerosus - A critical evaluation. J Reprod Med 1993;38:37-40.
106. 106. Sideri M, Origoni M, Spinaci L, et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obst 1994;46:53-6.
107. 107. Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991;78:1046-9.
108. 108. Punch MR, Ansbacher R. Autogenic masculinization. Am J Obst Gynecol 1990;163:114-6.
109. 109. Carli P, Cattaneo A, Taddei G, et al. Topical cyclosporin in the treatment of vulvar lichen sclerosus: Clinical, histological and immunohistological findings. Arch Dermatol 1992;128:1548-9.
110. 110. Virgili A, Corazza M, Bianchi A, et al. Open study of topical 0.25% tretinoin in the treatment of vulvar lichen sclerosis. One year of therapy. J Reprod Med 1995; 40:614-18.
111. 111. Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind placebo-controlled study. J Am Acad Dermatol 1994;30:225-31.
112. 112. Varani J, Mitra RS, Gibbs D, et al. All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human fibroblasts. J Invest Dermatol 1990;94:717-23.
113. 113. Priestly GC. Proliferation and glycosaminoglycan secretion in fibroblasts from psoriatic skin: differential responses to retinoids. Br J Dermatol 1987;117:575-83.
114. 114. Bergfield WF, Lesowitz SA. Lichen sclerosus et atrophicus. Arch Dermatol 1970;101:247-8.
115. 115. Everett MA, Coffey CM. Intradermal administration of chloroquine for discoid lupus erythematous and lichen sclerosus et atrophicus. Arch Dermatol 1961;83:977-9.
116. 116. Penneys NS. The treatment of lichen sclerosus et atrophicus with potassium para-aminobenzoate. J Am Acad Dermatol 1984;10:1039-42.
117. 117. Stuart G, Nation J, Malliah V, et al. Laser therapy of vulvar lichen sclerosus et atrophicus. Can J Surg 1991; 34:469-70.
118. 118. August PJ, Milward JM. Cryosurgery in the treatment of lichen sclerosus et atrophicus of the vulva. Br J Dermatol 1980;103:66-7.
119. 119. Meyrick Thomas RH, Kirby JD. Lichen sclerosus et atrophicus treated with cryotherapy. Br J Dermatol 67-8.
120. 120. Mering JH. A surgical approach to intractable pruritis vulvae. Am J Obstet Gynecol 1952;64:619-27.
121. 121. Paniel BJ, True JB, Decroix Y, et al. Vulvoperineoplasty. J Reprod Med 1986;31:983-4.
122. 122. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995;21:685-7.
123. 123. Gomez Rueda N, Garcia A, Vighi S, et al. Epithelial alterations adjacent to invasive squamous cell carcinoma of the vulva. J Reprod Med 1994;39:526-30.
124. 124. Wallace HJ, Whimster IW. Vulval atrophy and leukoplakia. Br J Dermatol 1951;63:241-57.
125. 125. Lessana-Liebowitch M, Poot M, Rizk-Rabin M, et al. Flow cytometric analysis of lichen sclerosus compared with normal vulvar skin and carcinoma in situ. Eur J Dermatol 1992;2:443-7.
126. 126. Ansink AC, Krul MR, DeWeger RA, et al. Human papilloma virus, lichen sclerosus and squamous cell carcinoma of the vulva: detection, and prognostic significance. Gynecol Oncol 1994;52:180-4.
127. 127. Karram M, Tabor B, Smotkin D, et al. Detection of human papilloma virus DNA from vulvar dystrophies and vulvar intraepithelial neoplastic lesions. Am J Obstet Gynecol 1988;159:22-3.
128. 128. Niell SM, Lessana-Liebowitch M, Pelisse M, et al. Lichen sclerosus, invasive squamous cell carcinoma and human papillomavirus. Am J Obst Gynecol 1990;162:1633-4.
129. 129. Anderson WA, Franquemont DW, Williams J, et al. Vulvar squamous cell carcinoma and papilloma viruses: Two separate entities? Am J Obst Gynecol 1991;165:329-36.
130. 130. Kien P, Milde-Langosh K, Löning T. Human papilloma virus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res 1991;283:445-8.
131. 131. Jeffcote TN. Chronic vulvar dystrophies. Am J Obstet Gynecol 1966;95:61-71.